The potential targeted drugs for fusion genes including NRG1 in pancreatic cancer
Kumiko Umemoto, Yu Sunakawa
Topics & Concepts
KRASCancer researchFusion proteinFusion genePancreatic cancerMedicineWild typeTyrosine kinaseNeuregulin 1CancerTargeted therapyNeuregulinKinaseBiologyGeneMutantInternal medicineColorectal cancerReceptorGeneticsRecombinant DNAPancreatic and Hepatic Oncology ResearchCancer Genomics and DiagnosticsLung Cancer Treatments and Mutations